Journal of Ginseng Research · 2023 · 20 citations · 37 references
MedicineCancer BiologyOncologyCancer PharmacologyCell SignalingMolecular OncologyApoptosis In CancerCancer Cell SignalingOncogenic Signaling PathwaysOvarian CancerTumor Suppressor GenesNf-kappa B-mediated Anti-apoptotic SignalingNf-κb SignalingNuclear Factor Kappa B InhibitionOvarian Cancer PathogenesisTumor Promoter MechanismsTumor Suppression Mechanisms
Ginsenoside 20(S)-Rg3 shows promising tumor-suppressive effects in ovarian cancer via inhibiting NF-κB signaling. This study aimed to explore the downstream tumor suppressive mechanisms of ginsenoside Rg3 via this signaling pathway. A systematical screening was applied to examine the expression profile of 41 kinesin family member genes in ovarian cancer. The regulatory effect of ginsenoside Rg3 on KIF20A expression was studied. In addition, we explored interacting proteins of KIF20A and their molecular regulations in ovarian cancer. RNA-seq data from The Cancer Genome Atlas (TCGA) was used for bioinformatic analysis. Epithelial ovarian cancer cell lines SKOV3 and A2780 were used as in vitro and in vivo cell models. Commercial human ovarian cancer tissue arrays were used for immunohistochemistry staining. KIF20A is a biomarker of poor prognosis among the kinesin genes. It promotes ovarian cancer cell growth in vitro and in vivo. Ginsenoside Rg3 can suppress the transcription of KIF20A. GST pull-down and co-immunoprecipitation (IP) assays confirmed that KIF20A physically interacts with BTRC (β-TrCP1), a substrate recognition subunit for SCFβ−TrCP E3 ubiquitin ligase. In vitro ubiquitination and cycloheximide (CHX) chase assays showed that via interacting with BTRC, KIF20A reduces BTRC-mediated CDC25A poly-ubiquitination and enhances its stability. Ginsenoside Rg3 treatment partly abrogates KIF20A overexpression-induced CDC25A upregulation. This study revealed a novel anti-tumor mechanism of ginsenoside Rg3. It can inhibit KIF20A transcription and promote CDC25A proteasomal degradation in epithelial ovarian cancer.
37
Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage
Luca Busino, Maddalena Donzelli, Massimo Chiesa et al. · Nature · 2003 · 440 citations
Julie G. Donaldson · Current Protocols in Cell Biology · 2015 · 121 citations
Medicine, Cell Biology, Immunology +17